| 1. |
Lewington S, Lacey B, Clarke R, et al. The burden of hypertension and associated risk for cardiovascular mortality in China. JAMA Intern Med, 2016, 176(4): 524-532.
|
| 2. |
Pullalarevu R, Akbar G, Teehan G. Secondary hypertension, issues in diagnosis and treatment. Prim Care, 2014, 41(4): 749-764.
|
| 3. |
Piaditis G, Markou A, Papanastasiou L, et al. Progress in aldosteronism: a review of the prevalence of primary aldosteronism in pre-hypertension and hypertension. Eur J Endocrinol, 2015, 172(5): R191-R203.
|
| 4. |
Fishman LM, Küchel O, Liddle GW, et al. Incidence of primary aldosteronism uncomplicated "essential" hypertension. A prospective study with elevated aldosterone secretion and suppressed plasma renin activity used as diagnostic criteria. JAMA, 1968, 205(7): 497-502.
|
| 5. |
Kaplan NM. Hypokalemia in the hypertensive patient, with observations on the incidence of primary aldosteronism. Ann Intern Med, 1967, 66(6): 1079-1090.
|
| 6. |
Hannemann A, Wallaschofski H. Prevalence of primary aldosteronism in patient’s cohorts and in population-based studies: a review of the current literature. Horm Metab Res, 2012, 44(3): 157-162.
|
| 7. |
Meng X, Li Y, Wang X, et al. Evaluation of the saline infusion test and the captopril challenge test in Chinese patients with primary aldosteronism. J Clin Endocrinol Metab, 2018, 103(3): 853-860.
|
| 8. |
Milliez P, Girerd X, Plouin PF, et al. Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism. J Am Coll Cardiol, 2005, 45(8): 1243-1248.
|
| 9. |
Funder JW, Carey RM, Mantero F, et al. The management of primary aldosteronism: case detection, diagnosis, and treatment: an endocrine society clinical practice guideline. J Clin Endocrinol Metab, 2016, 101(5): 1889-1916.
|
| 10. |
孫寧玲, 霍勇, 王繼光, 等. 難治性高血壓診斷治療中國專家共識. 中國醫學前沿雜志: 電子版, 2013(6): 5-12.
|
| 11. |
Montori VM, Young WF Jr. Use of plasma aldosterone concentration-to-plasma renin activity ratio as a screening test for primary aldosteronism. A systematic review of the literature. Endocrinol Metab Clin North Am, 2002, 31(3): 619-632.
|
| 12. |
Hiramatsu K, Yamada T, Yukimura Y, et al. A screening test to identify aldosterone-producing adenoma by measuring plasma renin activity. Results in hypertensive patients. Arch Intern Med, 1981, 141(12): 1589-1593.
|
| 13. |
Mckenna TJ, Sequeira SJ, Heffernan A, et al. Diagnosis under random conditions of all disorders of the renin-angiotensin-aldosterone axis, including primary hyperaldosteronism. J Clin Endocrinol Metab, 1991, 73(5): 952-957.
|
| 14. |
Mulatero P, Rabbia F, Milan A, et al. Drug effects on aldosterone/plasma renin activity ratio in primary aldosteronism. Am J Hypertens, 2002, 40(6): 897-902.
|
| 15. |
Nwariaku FE, Miller BS, Auchus R, et al. Primary hyperaldosteronism: effect of adrenal vein sampling on surgical outcome. Arch Surg, 2006, 141(5): 497-502; discussion 502-503.
|
| 16. |
Gordon RD. Diagnostic investigations in primary aldosteronism// Zanchetti A. Clinical medicine series on hypertension. London: McGraw-Hill International, 2001: 101-114.
|
| 17. |
Young WF, Stanson AW, Thompson GB, et al. Role for adrenal venous sampling in primary aldosteronism. Surgery, 2004, 136(6): 1227-1235.
|
